Fibromyalgia is a chronic condition that causes widespread pain all over the body, fatigue and poor sleep, and it often also causes problems with mood, memory and concentration. It affects about 2% of ...

LOS ANGELES (KABC) -- Fibromyalgia and chronic fatigue syndrome are two mysterious and debilitating conditions - and they're often confused with each other. Tiredness, pain, trouble concentrating and ...

You may have body aches, feel weak, or get dizzy in or after a shower ...

Fibromyalgia is a chronic condition that causes pain throughout the body, as well as fatigue. Research suggests that fibromyalgia happens when the body's central and peripheral nervous systems don't ...

Living with fibromyalgia means navigating a complex web of widespread pain, profound fatigue, and cognitive challenges that fluctuate in intensity from day to day. For the estimated 4% of the ...

"Fibromyalgia is a common condition affecting 3.7 million Americans. Fibromyalgia causes scattered pain, lack of energy, poor sleep and myriad other signs and symptoms. Because symptoms of many ...

Please provide your email address to receive an email when new articles are posted on . Quality of life, depression and anxiety were among the symptoms that improved after using the device. The device ...

Both exposure-based cognitive behavioral therapy (Exp- CBT) and traditional CBT may reduce symptoms of fibromyalgia. The corresponding study was published in Pain. Fibromyalgia is a chronic pain ...

A smartphone app that delivers acceptance and commitment therapy (ACT), a type of cognitive behavioral therapy, improves overall well-being and reduces the severity of pain, fatigue, sleep issues, and ...

PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

WOBURN, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) for Quell as a ...